Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.
“We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia.
The researchers landed on their breakthrough after discovering that inflammatory molecules known as leukotrienes are deregulated in Alzheimer’s disease and related dementias. In experiments in animals, they found that the leukotriene pathway plays an especially important role in the later stages of disease.
“At the onset of dementia, leukotrienes attempt to protect nerve cells, but over the long term, they cause damage,” Dr. Praticò said. “Having discovered this, we wanted to know whether blocking leukotrienes could reverse the damage, whether we could do something to fix memory and learning impairments in mice having already abundant tau pathology.”
To recapitulate the clinical situation of dementia in humans, in which patients are already symptomatic by the time they are diagnosed, Dr. Praticò and colleagues used specially engineered tau transgenic mice, which develop tau pathology – characterized by neurofibrillary tangles, disrupted synapses (the junctions between neurons that allow them to communicate with one another), and declines in memory and learning ability – as they age. When the animals were 12 months old, the equivalent of age 60 in humans, they were treated with zileuton, a drug that inhibits leukotriene formation by blocking the 5-lipoxygenase enzyme.
After 16 weeks of treatment, animals were administered maze tests to assess their working memory and their spatial learning memory. Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency.
To determine why this happened, the researchers first analyzed leukotriene levels. They found that treated tau mice experienced a 90-percent reduction in leukotrienes compared with untreated mice. In addition, levels of phosphorylated and insoluble tau, the form of the protein that is known to directly damage synapses, were 50 percent lower in treated animals. Microscopic examination revealed vast differences in synaptic integrity between the groups of mice. Whereas untreated animals had severe synaptic deterioration, the synapses of treated tau animals were indistinguishable from those of ordinary mice without the disease.
“Inflammation was completely gone from tau mice treated with the drug,” Dr. Praticò said. “The therapy shut down inflammatory processes in the brain, allowing the tau damage to be reversed.”
The study is especially exciting because zileuton is already approved by the Food and Drug Administration for the treatment of asthma. “Leukotrienes are in the lungs and the brain, but we now know that in addition to their functional role in asthma, they also have a functional role in dementia,” Dr. Praticò explained.
“This is an old drug for a new disease,” he added. “The research could soon be translated to the clinic, to human patients with Alzheimer’s disease.”
The Latest on: Dementia
[google_news title=”” keyword=”dementia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Dementia
- Southampton-based dementia debit card wins £125k Dragons Den investmenton March 4, 2024 at 9:57 pm
A business owner has secured £125k on Dragons' Den for her debit card and mobile app for people with dementia. Jayne Sibley, from Winchester, created Sibstar while caring for her parents, who were ...
- Biden medically cleared without dementia screening: When does memory loss merit cognitive testing?on March 4, 2024 at 8:52 pm
Another sign a person's memory loss is more than normal aging is when they don't realize they're forgetting things, said Dr. Thomas Wisniewski, director of NYU Langone Health’s Alzheimer’s Disease ...
- Burnsville police searching for 85-year-old man with dementiaon March 4, 2024 at 3:05 pm
The Burnsville Police Department says Jack Kilby was last seen leaving his residence in Burnsville around 11 a.m.
- We should all have the right to die on our own terms – current assisted-dying laws deny this to people with dementiaon March 4, 2024 at 1:38 pm
It’s important to ensure VAD is not abused, but life-expectancy restrictions mean many are denied the right to avoid an ignominious and drawn-out decline ...
- Bruce Willis’ wife Emma Heming slams claims he has ‘no more joy’ amid dementia battleon March 4, 2024 at 12:13 pm
One hundred percent, there is grief and sadness. There is all of that. But you start a new chapter and…filled with love.” — Emma Heming Willis.
- Bruce Willis' wife, Emma, says 'clickbait' articles about him having 'no joy' are untrue: Here's what to know about frontotemporal dementiaon March 4, 2024 at 11:40 am
"The headline basically says there is 'no more joy' in my husband," she said. "I can just tell you, that is far from the truth. I need society and whoever’s writing these stupid ...
- Meeting to discuss future of dementia supporton March 4, 2024 at 11:13 am
Torbay councillors are to look at the issue of dementia support at an upcoming meeting. The Devon council said its adult social care sub-board would explore how well dementia services and support work ...
- Emma Heming Willis slams claim Bruce Willis has 'no more joy' amid dementia battleon March 4, 2024 at 11:07 am
Emma Heming Willis spoke out after a report claimed Bruce Willis has "no more joy" following his aphasia and frontotemporal dementia diagnoses.
- Carers asked to share experiences of dementia careon March 4, 2024 at 8:26 am
Isle of Man carers have been invited to share their experiences in an effort to improve dementia services, Manx Care has said. The healthcare body is holding a series of events involving nurses, ...
via Bing News